Salmon Sean 4
4 · Medtronic plc · Filed Aug 6, 2024
Insider Transaction Report
Form 4
Salmon Sean
EVP & Group President Diabetes
Transactions
- Tax Payment
Ordinary Shares
2024-08-02$81.51/sh−657$53,552→ 67,889 total - Exercise/Conversion
Ordinary Shares
2024-08-02+5,462→ 68,546 total - Tax Payment
Ordinary Shares
2024-08-02$81.51/sh−2,779$226,516→ 65,110 total - Exercise/Conversion
Performance Share Units
2024-08-02−5,462→ 0 total→ Performance Share Units (5,462 underlying)
Footnotes (5)
- [F1]Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents, of which 4,369 shares will be delivered to the reporting person when his employment with the Company ends.
- [F2]Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024.
- [F3]Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.
- [F4]Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
- [F5]The performance share units vested on August 2, 2024.